Malignant neoplasm of peripheral nerves and autonomic nervous system
Chapter 2:Neoplasms
ICD-10 C47 is a billable code used to indicate a diagnosis of malignant neoplasm of peripheral nerves and autonomic nervous system.
C47 refers to malignant neoplasms that arise from the peripheral nerves and the autonomic nervous system. These tumors can originate from Schwann cells, perineural cells, or other nerve-associated tissues. The most common types include malignant peripheral nerve sheath tumors (MPNSTs), which often occur in patients with neurofibromatosis type 1. These tumors can be aggressive, with a tendency to metastasize, and may present with symptoms such as pain, neurological deficits, or palpable masses. Diagnosis typically involves imaging studies such as MRI or CT scans, followed by biopsy for histological confirmation. Treatment often requires a multidisciplinary approach, including surgical resection, radiation therapy, and chemotherapy, depending on the tumor's size, location, and grade. Grading of these tumors is crucial, as it influences prognosis and treatment decisions. Accurate coding is essential for appropriate reimbursement and tracking of treatment outcomes.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis and management of MPNSTs, treatment planning for sarcomas.
Ensure accurate staging and grading are documented for treatment planning.
Neurological assessments, imaging results, and symptom documentation.
Evaluation of neurological deficits due to peripheral nerve tumors.
Document neurological symptoms clearly to support coding.
Used when lymph nodes are sampled for staging of peripheral nerve tumors.
Pathology report and imaging studies.
Oncology specialists should ensure thorough documentation of findings.
Grading indicates the aggressiveness of the tumor and helps guide treatment decisions. Higher-grade tumors typically require more aggressive treatment.
